Loading company
Latest annual · FY2025
Millions- Total revenues
- 116
- Gross profit
- 24
- Operating income
- (71)
- Net income
- (70)
- Free cash flow
- 12
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- -23.5%
Zhengye Biotechnology Holding Ltd (ZYBT) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | CN¥116.4 million | CN¥186.4 million | -37.6% | 20-F 2026-04-28 · proof |
| Gross profit | CN¥23.9 million | CN¥91.3 million | -73.9% | 20-F 2026-04-28 · proof |
| Operating income | -CN¥70.5 million | CN¥16.4 million | -528.9% | 20-F 2026-04-28 · proof |
| Net income | -CN¥69.8 million | CN¥11.3 million | -717% | 20-F 2026-04-28 · proof |
| Cash from operating activities | CN¥13.3 million | CN¥41 million | -67.5% | 20-F 2026-04-28 · proof |
| Free cash flow | CN¥12.3 million | CN¥27.5 million | -55.1% | 20-F 2026-04-28 · proof |
| Total assets | CN¥436.5 million | CN¥493.2 million | -11.5% | 20-F 2026-04-28 · proof |
| Total liabilities | CN¥129.8 million | CN¥140.7 million | -7.8% | 20-F 2026-04-28 · proof |
| Cash and cash equivalents | CN¥50.3 million | CN¥18.6 million | +170.5% | 20-F 2026-04-28 · proof |
| Total debt | CN¥75.4 million | CN¥86.4 million | -12.8% | 20-F 2026-04-28 · proof |
- What was Zhengye Biotechnology Holding Ltd (ZYBT)'s revenue in fiscal 2025?
- Zhengye Biotechnology Holding Ltd (ZYBT) reported revenue of CN¥116.4 million for fiscal 2025 (the year ended Dec 31, 2025), against CN¥186.4 million the year before (-37.6%). Source: the 20-F filed with the SEC on Apr 28, 2026. SEC
- What was Zhengye Biotechnology Holding Ltd (ZYBT)'s gross profit in fiscal 2025?
- Zhengye Biotechnology Holding Ltd (ZYBT) reported gross profit of CN¥23.9 million for fiscal 2025 (the year ended Dec 31, 2025), against CN¥91.3 million the year before (-73.9%). Source: the 20-F filed with the SEC on Apr 28, 2026. SEC
- What was Zhengye Biotechnology Holding Ltd (ZYBT)'s operating income in fiscal 2025?
- Zhengye Biotechnology Holding Ltd (ZYBT) reported operating income of -CN¥70.5 million for fiscal 2025 (the year ended Dec 31, 2025), against CN¥16.4 million the year before (-528.9%). Source: the 20-F filed with the SEC on Apr 28, 2026. SEC
- What was Zhengye Biotechnology Holding Ltd (ZYBT)'s net income in fiscal 2025?
- Zhengye Biotechnology Holding Ltd (ZYBT) reported net income of -CN¥69.8 million for fiscal 2025 (the year ended Dec 31, 2025), against CN¥11.3 million the year before (-717%). Source: the 20-F filed with the SEC on Apr 28, 2026. SEC
- What was Zhengye Biotechnology Holding Ltd (ZYBT)'s cash from operating activities in fiscal 2025?
- Zhengye Biotechnology Holding Ltd (ZYBT) reported cash from operating activities of CN¥13.3 million for fiscal 2025 (the year ended Dec 31, 2025), against CN¥41 million the year before (-67.5%). Source: the 20-F filed with the SEC on Apr 28, 2026. SEC
- What was Zhengye Biotechnology Holding Ltd (ZYBT)'s free cash flow in fiscal 2025?
- Zhengye Biotechnology Holding Ltd (ZYBT) reported free cash flow of CN¥12.3 million for fiscal 2025 (the year ended Dec 31, 2025), against CN¥27.5 million the year before (-55.1%). Source: the 20-F filed with the SEC on Apr 28, 2026. SEC
- What are Zhengye Biotechnology Holding Ltd (ZYBT)'s total assets?
- As of Dec 31, 2025, Zhengye Biotechnology Holding Ltd (ZYBT) reported total assets of CN¥436.5 million, against CN¥493.2 million a year earlier (-11.5%). Source: the 20-F filed with the SEC on Apr 28, 2026. SEC
- What are Zhengye Biotechnology Holding Ltd (ZYBT)'s total liabilities?
- As of Dec 31, 2025, Zhengye Biotechnology Holding Ltd (ZYBT) reported total liabilities of CN¥129.8 million, against CN¥140.7 million a year earlier (-7.8%). Source: the 20-F filed with the SEC on Apr 28, 2026. SEC
- What are Zhengye Biotechnology Holding Ltd (ZYBT)'s cash and cash equivalents?
- As of Dec 31, 2025, Zhengye Biotechnology Holding Ltd (ZYBT) reported cash and cash equivalents of CN¥50.3 million, against CN¥18.6 million a year earlier (+170.5%). Source: the 20-F filed with the SEC on Apr 28, 2026. SEC
- What is Zhengye Biotechnology Holding Ltd (ZYBT)'s total debt?
- As of Dec 31, 2025, Zhengye Biotechnology Holding Ltd (ZYBT) reported total debt of CN¥75.4 million, against CN¥86.4 million a year earlier (-12.8%). Source: the 20-F filed with the SEC on Apr 28, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:ZYBT&period_type=annual&limit=5"Information only, not investment advice.